TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Somnomed Limited ( (AU:SOM) ) has issued an announcement.
Somnomed Limited announced a change in the director’s interest, with Amrita Singh Blickstead acquiring 1,700,000 options, increasing her total options to 1,885,000. This change, approved at the Annual General Meeting, reflects the company’s ongoing commitment to aligning its leadership’s interests with its strategic goals, potentially impacting its market position and stakeholder confidence.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on the production and distribution of oral appliances for the treatment of sleep-related disorders, particularly obstructive sleep apnea. The company is known for its innovative solutions that cater to both patients and healthcare providers, aiming to improve sleep health globally.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
For an in-depth examination of SOM stock, go to TipRanks’ Overview page.